Oxidative stress and DNA interactions are not involved in enniatin- and beauvericin-mediated apoptosis induction

Molecular Nutrition and Food Research

Volumn 53, Issue 9, 2009, Pages 1112-1122

  Dornetshuber, Rita ^a,b   Heffeter, Petra ^a   Lemmens Gruber, Rosa ^b   Elbling, Leonilla ^a   Marko, Doris ^c   Micksche, Michael ^a   Berger, Walter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Beauvericin; DNA damage; Enniatin; Fusarium mycotoxins; Oxidative stress

Indexed keywords

ANTIOXIDANT; BEAUVERICIN; DEPSIPEPTIDE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ENNIATINS;

APOPTOSIS; ARTICLE; DNA DAMAGE; DNA REPAIR; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; OXIDATIVE STRESS; TUMOR CELL LINE;

ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; DEPSIPEPTIDES; DNA DAMAGE; DNA REPAIR; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; HUMANS; OXIDATIVE STRESS;

ATAXIA TELANGIECTASIA; FUSARIUM;

EID: 70349639418     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800571     Document Type: Article

References (60)

1. Jestoi, M., Emerging fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin: a review, Crit. Rev. Food Sci. Nutr. 2008, 48, 21-49.
2. Kamyar, M., Rawnduzi, P., Studenik, C. R., Kouri, K., Lemmens-Gruber, R., Investigation of the electrophysiological properties of enniatins, Arch. Biochem. Biophys. 2004, 429, 215-223.
3. Kouri, K., Kamyar, M. R., Lemmens-Gruber, R., Actions of the antibiotic mycotoxins beauvericin and enniatin on mammalian tissue, Forum. Nutr. 2003, 56, 413-414.
4. Kleinkauf, H., von Dohren, H., Nonribosomal biosynthesis of peptide antibiotics, Eur. J. Biochem. 1990, 192, 1-15.
5. Dornetshuber, R., Heffeter, P., Kamyar, M. R., Peterbauer, T. et al., Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells, Chem. Res. Toxicol. 2007, 20, 465-473.
6. Jow, G. M., Chou, C. J., Chen, B. F., Tsai, J. H., Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium, Cancer Lett. 2004, 216, 165-173.
7. Lin, H. I., Lee, Y. J., Chen, B. F., Tsai, M. C., et al., Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human nonsmall cell lung cancer cells, Cancer Lett. 2005, 230, 248-259.
8. Xu, Y., Zhan, J., Wijeratne, E. M., Burns, A. M., et al., Cytotoxic and antihaptotactic beauvericin analogues from precursor-directed biosynthesis with the insect pathogen beauveria bassiana ATCC 7159, J. Nat. Prod. 2007, 70, 1467-1471.
9. Zhan, J., Burns, A. M., Liu, M. X., Faeth, S. H., Gunatilaka, A. A., Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum, J. Nat. Prod. 2007, 70, 227-232.
10. Brown, A. P., Morrissey, R. L., Faircloth, G. T., Levine, B. S., Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat, Cancer Chemother. Pharmacol. 2002, 50, 333-340.
11. Fecteau, K. A., Mei, J., Wang, H. C., Differential modulation of signaling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228, J. Pharmacol. Exp. Ther. 2002, 300, 890-899.
12. Boulares, A. H., Contreras, F. J., Espinoza, L. A., Smulson, M. E., Roles of oxidative stress and glutathione depletion in JP-8 jet fuel-induced apoptosis in rat lung epithelial cells, Toxicol. Appl. Pharmacol. 2002, 180, 92-99.
13. Higuchi, Y., Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis, J. Cell Mol. Med. 2004, 8, 455-464.
14. Kouadio, J. H., Mobio, T. A., Baudrimont, I., Moukha, S., et al., Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2, Toxicology 2005, 213, 56-65.
15. Rigas, B., Sun, Y., Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer, Br. J. Cancer 2008, 98, 1157-1160.
16. Stockmann-Juvala, H., Mikkola, J., Naarala, J., Loikkanen, J., et al., Oxidative stress induced by fumonisin B1 in continuous human and rodent neural cell cultures, Free Radic. Res. 2004,38,933-942.
17. Klaric, M. S., Pepeljnjak, S., Domijan, A. M., Petrik, J., Lipid peroxidation and glutathione levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B(1), beauvericin and ochratoxin A, Basic. Clin. Pharmacol. Toxicol. 2007, 100, 157-164.
18. Paciolla, C., Dipierro, N., Mule, G., Logrieco, A., Dipierro, S., The mycotoxins beauvericin and T-2 induce cell death and alteration to the ascorbate metabolism in tomato prtoplasts, Physiol. Mol. Plant. Pathol. 2004, 65, 49-56.
19. Guengerich, F. P., Johnson, W. W., Shimada, T., Ueng, Y. F., et al., Activation and detoxication of aflatoxin B1, Mutat. Res. 1998,402,121-128.
20. Larson, E. D., Drummond, J. T., Human mismatch repair and G*T mismatch binding by hMutSalpha in vitro is inhibited by adriamycin, actinomycin D, and nogalamycin, J. Biol. Chem. 2001,276,9775-9783.
21. Berger, W., Micksche, M., Elbling, L., Effects of multidrug resistance-related ATP-binding-cassette transporter proteins on the cytoskeletal activity of cytochalasins, Exp. Cell Res. 1997,237,307-317.
22. Shen, D. W., Cardarelli, C., Hwang, J., Cornwell, M., et al., Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins, J. Biol. Chem. 1986, 261, 7762-7770.
23. McGrath, T., Center, M. S., Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug, Cancer Res. 1988, 48, 3959-3963.
24. Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., et al., Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N -nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation, Cancer Res. 1994, 54, 4308-4312.
25. Gozukara, E. M., Parris, C. N., Weber, C. A., Salazar, E. P., et al., The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells, Cancer Res. 1994, 54, 3837-3844.
26. Levy, D. D., Saijo, M., Tanaka, K., Kraemer, K. H., Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids, Carcinogenesis 1995, 16,1557-1563.
27. Elbling, L., Weiss, R. M., Teufelhofer, O., Uhl, M., et al., Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities, Faseb J. 2005, 19, 807-809.
28. Heffeter, P., Jakupec, M. A., Korner, W., Wild, S., et al., Anti-cancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24), Biochem. Pharmacol. 2006, 71, 426-440.
29. Korynevska, A., Heffeter, P., Matselyukh, B., Elbling, L., et al., Mechanisms underlying the anticancer activities of the angucycline landomycin E, Biochem. Pharmacol. 2007, 74, 1713-1726.
30. Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., et al., Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing, Environ. Mol. Mutagen 2000, 35, 206-221.
31. Burlinson, B., Tice, R. R., Speit, G., Agurell, E., et al., Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup, Mutat. Res. 2007, 627, 31-35.
32. Colella, G., Bonfanti, M., D'Incalci, M., Broggini, M., Characterization of a protein recognizing minor groove binders damaged DNA, Nucleic Acids Res. 1996, 24, 4227-4233.
33. Jolles, B., Laigle, A., Priebe, W., Garnier-Suillerot, A., Comparison of DNA sequence selectivity of anthracycline antibiotics and their 39-hydroxylated analogs, Chem. Biol. Interact. 1996,100,165-176.
34. Habermeyer, M., Fritz, J., Barthelmes, H. U., Christensen, M. O. et al., Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity, Chem. Res. Toxicol. 2005, 18, 1395-1404.
35. Calo, L., Fornelli, F., Nenna, S., Tursi, A., et al., Beauvericin cytotoxicity to the invertebrate cell line SF-9, J. Appl. Genet. 2003,44,515-520.
36. Dombrink-Kurtzman, M. A., Fumonisin and beauvericin induce apoptosis in turkey peripheral blood lymphocytes, Mycopathologia 2003, 156, 357-364.
37. Ojcius, D. M., Zychlinsky, A., Zheng, L. M., Young, J. D., Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes, Exp. Cell. Res. 1991, 197, 43-49.
38. Calo, L., Fornelli, F., Ramires, R., Nenna, S., et al., Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin, Pharmacol. Res. 2004, 49, 73-77.
39. Kehrer, J. P., Paraidathathu, T., The use of fluorescent probes to assess oxidative processes in isolated-perfused rat heart tissue, Free Radic. Res. Commun. 1992, 16, 217-225.
40. Speit, G., Hartmann, A., The comet assay: a sensitive genotoxicity test for the detection of DNA damage, Methods Mol. Biol. 2005, 291, 85-95.
41. Dornetshuber, R., Heffeter, P., Sulyok, M., Schumacher, R., et al., Interactions between ABC-transport proteins and the secondary fusarium metabolites enniatin and beauvericin, Mol. Nutr. Food Res. 2009, 53, 904-920.
42. [42] Galvano, F., Russo, A., Cardile, V., Galvano, G., et al., DNA damage in human fibroblasts exposed to fumonisin B(1),Food Chem. Toxicol. 2002, 40, 25-31.
43. Galvano, F., Campisi, A., Russo, A., Galvano, G., et al., DNA damage in astrocytes exposed to fumonisin B1, Neurochem. Res. 2002, 27, 345-351.
44. Deneke, S. M., Fanburg, B. L., Regulation of cellular glutathione, Am. J. Physiol. 1989, 257, L163-173.
45. Loutelier, C., Cherton, J. C., Lange, C., Conjugation reactions of cyclodepsipeptide to glutathionyl adducts by direct in-beam' synthesis under negative-ion fast-atom bombardment conditions, Rapid Commun. Mass Spectrom. 1994, 8, 844-848.
46. Loutelier, C., Marcual, A., Cherton, J. C., Lange, C., Characterization of cyclodepsipeptide-glutathionyl conjugates by negative-ion fast-atom bombardment linked-scan mass spectrometry, Rapid Commun. Mass Spectrom. 1994, 8, 957-959.
47. Theumer, M. G., Lopez, A. G., Masih, D. T., Chulze, S. N., Rubinstein, H. R., Immunobiological effects of fumonisin B1 in experimental subchronic mycotoxicoses in rats, Clin. Diagn. Lab Immunol. 2002, 9, 149-155.
48. Wassermann, K., Markovits, J., Jaxel, C., Capranico, G., et al., Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. Mol. Pharmacol. 1990, 38, 38-45.
49. Snyder, R. D., Assessment of atypical DNA intercalating agents in biological and in silico systems, Mutat. Res. 2007, 623,72-82.
50. Kamitori, S., Takusagawa, F., Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D, J. Mol. Biol. 1992, 225, 445-456.
51. Pocsfalvi, G., Di Landa, G., Ferranti, P., Ritieni, A., et al., Observation of noncovalent interactions between beauvericin and oligonucleotides using electrospray ionization mass spectrometry, Rapid Commun. Mass Spectrom. 1997, 11, 265-272.
52. Tse-Dinh, Y. C., Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases, Infect Disord. Drug Targets 2007, 7, 3-9.
53. Hwang, Y., Rowley, D., Rhodes, D., Gertsch, J., et al., Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A, Mol. Pharmacol. 1999, 55, 1049-1053.
54. Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., et al., The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage, Nature 1999, 399, 806-809.
55. Gatz, S. A., Wiesmuller, L., p53 in recombination and repair, Cell Death Differ. 2006, 13, 1003-1016.
56. Bernstein, C., Bernstein, H., Payne, C. M., Garewal, H., DNA repair/proapoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis, Mutat. Res. 2002, 511, 145-178.
57. Ueda, M., Ichihashi, M., [Xeroderma pigmentosum], Nippon Rinsho 1995, 53, 2815-2820.
58. Roos, W. P., Kaina, B., DNA damage-induced cell death by apoptosis, Trends Mol. Med. 2006, 12, 440-450.
59. Sarkaria, J. N., Eshleman, J. S., ATM as a target for novel radiosensitizers, Semin. Radiat. Oncol. 2001, 11, 316-327.
60. Hampson, R., Selection for genome instability by DNA damage in human cells: unstable microsatellites and their consequences for tumourigenesis, Radiat. Oncol. Investig. 1997, 5, 111-114.